ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.D. will present at the Rodman & Renshaw 13th Annual Healthcare Conference at 4:05 p.m. EDT on Tuesday, September 13, 2011. The conference will be held at The Waldorf Astoria Hotel in New York. Dr. West will provide updates on product development by BioTime and its subsidiaries OncoCyte Corporation and ReCyte Therapeutics, Inc.
